» Articles » PMID: 38680957

Cellular Senescence As a Targetable Risk Factor for Cardiovascular Diseases: Therapeutic Implications: Family Series

Overview
Date 2024 Apr 29
PMID 38680957
Authors
Affiliations
Soon will be listed here.
Abstract

The prevalence of cardiovascular diseases markedly rises with age. Cellular senescence, a hallmark of aging, is characterized by irreversible cell cycle arrest and the manifestation of a senescence-associated secretory phenotype, which has emerged as a significant contributor to aging, mortality, and a spectrum of chronic ailments. An increasing body of preclinical and clinical research has established connections between senescence, senescence-associated secretory phenotype, and age-related cardiac and vascular pathologies. This review comprehensively outlines studies delving into the detrimental impact of senescence on various cardiovascular diseases, encompassing systemic atherosclerosis (including coronary artery disease, stroke, and peripheral arterial disease), as well as conditions such as hypertension, congestive heart failure, arrhythmias, and valvular heart diseases. In addition, we have preclinical studies demonstrating the beneficial effects of senolytics-a class of drugs designed to eliminate senescent cells selectively across diverse cardiovascular disease scenarios. Finally, we address knowledge gaps on the influence of senescence on cardiovascular systems and discuss the future trajectory of strategies targeting senescence for cardiovascular diseases.

Citing Articles

Analysis of cellular senescence-related genes in calcified aortic valve disease and the potential therapeutic role of β-Carotene.

Tao Y, Gao C, Wang J, Zhang Q, Wang Z, Han L PLoS One. 2025; 20(3):e0318574.

PMID: 40063555 PMC: 11892872. DOI: 10.1371/journal.pone.0318574.


Regulatory Roles of Exosomes in Aging and Aging-Related Diseases.

Xiao N, Li Q, Liang G, Qian Z, Lin Y, Zhang H Biogerontology. 2025; 26(2):61.

PMID: 39966192 DOI: 10.1007/s10522-025-10200-7.


Cardiovascular Disease and Cancer: A Dangerous Liaison.

Newman A, Dalman J, Moore K Arterioscler Thromb Vasc Biol. 2025; 45(3):359-371.

PMID: 39781742 PMC: 11864891. DOI: 10.1161/ATVBAHA.124.319863.


The Implications of Aging on Vascular Health.

Ahmed B, Rahman A, Lee S, Malhotra R Int J Mol Sci. 2024; 25(20).

PMID: 39456971 PMC: 11508873. DOI: 10.3390/ijms252011188.


Regulatory Effects of Senescent Mesenchymal Stem Cells: Endotheliocyte Reaction.

Ratushnyy A, Ezdakova M, Matveeva D, Tyrina E, Buravkova L Cells. 2024; 13(16.

PMID: 39195236 PMC: 11352319. DOI: 10.3390/cells13161345.


References
1.
Weinberger M, Fineberg N . Sodium and volume sensitivity of blood pressure. Age and pressure change over time. Hypertension. 1991; 18(1):67-71. DOI: 10.1161/01.hyp.18.1.67. View

2.
De Paoli F, Staels B, Chinetti-Gbaguidi G . Macrophage phenotypes and their modulation in atherosclerosis. Circ J. 2014; 78(8):1775-81. DOI: 10.1253/circj.cj-14-0621. View

3.
Triana-Martinez F, Picallos-Rabina P, Da Silva-Alvarez S, Pietrocola F, Llanos S, Rodilla V . Identification and characterization of Cardiac Glycosides as senolytic compounds. Nat Commun. 2019; 10(1):4731. PMC: 6803708. DOI: 10.1038/s41467-019-12888-x. View

4.
Childs B, Baker D, Wijshake T, Conover C, Campisi J, van Deursen J . Senescent intimal foam cells are deleterious at all stages of atherosclerosis. Science. 2016; 354(6311):472-477. PMC: 5112585. DOI: 10.1126/science.aaf6659. View

5.
Suda M, Shimizu I, Katsuumi G, Yoshida Y, Hayashi Y, Ikegami R . Senolytic vaccination improves normal and pathological age-related phenotypes and increases lifespan in progeroid mice. Nat Aging. 2023; 1(12):1117-1126. DOI: 10.1038/s43587-021-00151-2. View